Is Prehypertension Really Different from Normotension and Hypertension? A Case-Control Pilot Proteomic Study in Chinese

References

• Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet 2005; 365: 217–223
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr, Jones DW, Materson BJ, Oparil S, Wright JT, Jr, Roccella EJ. The seven report of joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42: 1206–1252
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the New National Committee Guidelines. Arch Intern Med 2004; 164: 2126–2134
   PubMed Web of Science ®Google Scholar
• Bolli P, Hemmelgarn B, Myers MG, McKay D, Tremblay G, Tobe SW. High normal blood pressure and prehypertension: The debate continues. Can J Cardiol 2007; 23: 581–583
   PubMed Web of Science ®Google Scholar
• Izzo JL, Jr. Prehypertension: Demographics, pathophysiology, and treatment. Curr Hypertens Rep 2007; 9: 264–268
   PubMed Web of Science ®Google Scholar
• Anderson NL, Anderson NG. The human plasma proteome. Mol Cell Proteomics 2002; 1: 845–867
   PubMed Web of Science ®Google Scholar
• Shankar A, Li J. Association between serum gamma-glutamyltransferase level and prehypertension among US adults. Circ J 2007; 71: 1567–1572
   PubMed Web of Science ®Google Scholar
• Papadopoulos DP, Makris TK, Krespi PG, Poulakou M, Stavroulakis G, Hatzizacharias AN, Perrea D, Votteas VV. Adiponectin and resistin plasma levels in healthy individuals with prehypertension. J Clin Hypertens (Greenwich) 2005; 7: 729–733
   PubMedGoogle Scholar
• Jin X, Xia L, Wang LS, Shi JZ, Zheng Y, Chen WL, Zhang L, Liu ZG, Chen GQ, Fang NY. Differential protein expression in hypertrophic heart with and without hypertension in spontaneously hypertensive rats. Proteomics 2006; 6: 1948–1956
   PubMed Web of Science ®Google Scholar
• Lee JE, Kim YG, Choi YH, Huh W, Kim DJ, Oh HY. Serum uric acid is associated with microalbuminuria in prehypertension. Hypertension 2006; 47: 962–967
   PubMed Web of Science ®Google Scholar
• Yan JX, Wait R, Berkelman T, Harry RA, Westbrook JA, Wheeler CH, Dunn MJ. A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 2000; 21: 3666–3672
   PubMed Web of Science ®Google Scholar
• Nakajima K, Hamanoue M, Takemoto N, Hattori T, Kato K, Kohsaka S. Plasminogen binds specifically to α-enolase on rat neuronal plasma membrane. J Neurochem 1994; 63: 2048–2057
   PubMed Web of Science ®Google Scholar
• Cloix F, Devynck MA, Brentano JL, Meyer P. Plasma protein changes in primary hypertension in humans and rats. Hypertension 1983; 5: 128–134
   PubMed Web of Science ®Google Scholar
• Shen B, El-Dahr SS. Cross-talk of the renin-angiotensin and kallikrein-kinin systems. Biol Chem 2006; 387: 145–150
   PubMed Web of Science ®Google Scholar
• Savoia C, Schiffrin EL. Inflammation in hypertension. Curr Opin Nephrol Hypertens 2006; 15: 152–158
   PubMed Web of Science ®Google Scholar
• Sonmez A, Dogru T, Yilmaz MI, Ocal R, Ozgurtas T, Kilic S, Eyileten T, Tasci I, Erbil K, Kocar IH. Soluble CD40 ligand levels in patients with hypertension. Clin Exp Hypertens 2005; 27: 629–634
   PubMed Web of Science ®Google Scholar
• Madej A, Okopien B, Kowalski J, Haberka M, Herman ZS. Plasma concentrations of adhesion molecules and chemokines in patients with essential hypertension. Pharmacol Rep 2005; 57: 878–881
   PubMed Web of Science ®Google Scholar
• Manabe S, Okura T, Watanabe S, Fukuoka T, Higaki J. Effects of angiotensin II receptor blockade with valsartan on pro-inflammatory cytokines in patients with essential hypertension. J Cardiovasc Pharmacol 2005; 46: 735–739
   PubMed Web of Science ®Google Scholar
• Das UN. Hypertension as a low-grade systemic inflammatory condition that has its origins in the perinatal period. J Assoc Physicians India 2006; 54: 133–142
   PubMedGoogle Scholar
• Savoia C, Schiffrin EL. Vascular inflammation in hypertension and diabetes: Molecular mechanisms and therapeutic interventions. Clin Sci (Lond) 2007; 112: 375–384
   PubMed Web of Science ®Google Scholar
• King DE, Egan BM, Mainous AG, Geesey ME. Elevation of C-reactive protein in people with prehypertension. J Clin Hypertens (Greenwich) 2004; 6: 562–568
   PubMedGoogle Scholar
• Carter K, Worwood M. Haptoglobin: A review of the major allele frequencies worldwide and their association with diseases. Int J Lab Hematol 2007; 29: 92–110
   PubMed Web of Science ®Google Scholar
• Garfagnini A, Devoto G, Rosselli P, Boggiano P, Venturini M. Relationship between HDL-cholesterol and apolipoprotein A1 and the severity of coronary artery disease. Eur Heart J 1995; 16: 465–470
   PubMed Web of Science ®Google Scholar
• Carriere V, Vidal R, Lazou K, Lacasa M, Delers F, Ribeiro A, Rousset M, Chambaz J, Lacorte JM. HNF-4-dependent induction of apolipoprotein A-IV gene 2 transcription by an apical supply of lipid micelles in intestinal cells. J Biol Chem 2005; 280: 5406–5413
   PubMed Web of Science ®Google Scholar
• Trougakos IP, Lourda M, Agiostratidou G, Kletsas D, Gonos ES. Differential effects of clusterin/apolipoprotein J on cellular growth and survival. Free Radic Biol Med 2005; 38: 436–449
   PubMed Web of Science ®Google Scholar
• http://www.ncbi.nlm.nih.gov, Naya M, Tsukamoto T, Morita K, Katoh C, Furumoto T, Fujii S, Tamaki N, Tsutsui H. Plasma interleukin-6 and tumor necrosis factor-alpha can predict coronary endothelial dysfunction in hypertensive patients. Hypertens Res 2007; 30:541–548
   Google Scholar
• Steinberg D. Hypercholesterolemia and inflammation in atherogenesis: Two sides of the same coin. Mol Nutr Food Res 2005; 49: 995–998
   PubMed Web of Science ®Google Scholar
• Piro M, Giubilato G, Pinnelli M, Giordano Sciacca P, Biasucci LM. Endothelium and inflammation. Panminerva Med 2005; 47: 75–80
   PubMed Web of Science ®Google Scholar
• Vidt DG. Angiotensin-receptor blockers for prehypertension. Curr Hypertens Rep 2006; 8: 361–362
   PubMed Web of Science ®Google Scholar
• Nesbitt SD. Perspectives on prehypertension. J Cardiometab Syndr 2006; 1: 364–365
   PubMedGoogle Scholar
• Julius S, Nesbitt SD, Egan BM, Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, Black HR, Grimm RH, Jr, Messerli FH, Oparil S, Schork MA. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006; 354: 1685–1697
   PubMed Web of Science ®Google Scholar
• Lee PS, Waxman AB, Cotich KL, Chung SW, Perrella MA, Stossel TP. Plasma gelsolin is a marker and therapeutic agent in animal sepsis. Crit Care Med 2007; 35: 849–855
   PubMed Web of Science ®Google Scholar
• Bao Y, Bing C, Hunter L, Jenkins JR, Wabitsch M, Trayhurn P. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SGBS) adipocytes. FEBS Lett 2005; 579: 41–47
   PubMed Web of Science ®Google Scholar
• Stenvinkel P, Wang K, Qureshi AR, Axelsson J, Pecoits-Filho R, Gao P, Barany P, Lindholm B, Jogestrand T, Heimbürger O, Holmes C, Schalling M, Nordfors L. Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Kidney Int 2005; 67: 2383–2392
   PubMed Web of Science ®Google Scholar
• Jones AL, Hulett MD, Parish CR. Histidine-rich glycoprotein: A novel adaptor protein in plasma that modulates the immune, vascular and coagulation systems. Immunol Cell Biol 2005; 83: 106–118
   PubMed Web of Science ®Google Scholar
• Erdogan D, Caliskan M, Yildirim I, Gullu H, Baycan S, Ciftci O, Yildirir A, Muderrisoglu H. Effects of normal blood pressure, prehypertension and hypertension on left ventricular diastolic function and aortic elastic properties. Blood Press 2007; 16: 114–121
   PubMed Web of Science ®Google Scholar
• Ninomiya T, Kubo M, Doi Y, Yonemoto K, Tanizaki Y, Tsuruya K, Sueishi K, Tsuneyoshi M, Iida M, Kiyohara Y. Prehypertension increases the risk for renal arteriosclerosis in autopsies: The Hisayama Study. J Am Soc Nephrol 2007; 18: 2135–2142
   PubMed Web of Science ®Google Scholar
• Irene G, Haralambos G. Hypertension, vasoactive peptides and coagulation factors. J Hypertens 2004; 22: 1091–1092
   PubMed Web of Science ®Google Scholar
• Armas-Hernández MJ, Hernández-Hernández R, Armas-Padilla MC, Sosa-Canache B, Cammarata R, Pacheco B, Guerrero-Pajuelo J, Israili ZH, Valasco M. Fibrinolytic system in normotensive subjects and hypertensive patients. Am J Ther 2007; 14: 177–182
   PubMedGoogle Scholar
• Kakar P, Lip GY. Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapy. Expert Rev Cardiovasc Ther 2007; 5: 441–450
   PubMedGoogle Scholar
• Barath A, Nemeth I, Karg E, Endreffy E, Bereczki C, Gellén B, Haszon I, Túri S. Roles of paraoxonase and oxidative stress in adolescents with uremia, essential or obesity-induced hypertension. Kidney Blood Press Res 2006; 29: 144–151
   PubMed Web of Science ®Google Scholar
• Tandon R, Sinha MK, Garg H, Khanna R, Khanna HD. Oxidative stress in patients with essential hypertension. Natl Med J India 2005; 18: 297–299
   PubMed Web of Science ®Google Scholar
• Vari IS, Balkau B, Kettaneh A, André P, Tichet J, Fumeron F, Caces E, Marre M, Grandchamp B, Ducimetière P. Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2007; 30: 1795–1801
   PubMed Web of Science ®Google Scholar